Tibet Weixinkang Pharmaceutical Co Ltd. Stock Analysis 603676.SS

Xizang Weixinkang Pharmaceutical Co., Ltd. engages in the research and development, production and sale of pharmaceutical products. The company is headquartered in Lhasa, Xizang and currently employs 763 full-time employees. The company went IPO on 2017-07-21. The main products include intravenous vitamins, multivitamins for injection (12), multi-trace element injections, pediatric multivitamin injections (13), pediatric compound amino acid injections, inhaled acetylcysteine ​​solution, compound electrolyte injections, mixed sugar electrolyte injections, potassium aspartate injections, potassium magnesium aspartate injections, and sucrose iron injections. The firm is also engaged in market management and promotion service businesses. The firm operates its businesses in the domestic market.